Clinical Trials Directory

Trials / Sponsors / Atom Therapeutics Co., Ltd

Atom Therapeutics Co., Ltd

Industry · 11 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEfficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Phase 22026-04-01
Not Yet RecruitingEvaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
Chronic Kidney Disease
Phase 22026-02-01
RecruitingDrug-Drug Interaction Study of ABP-671 in Gout Patients
Gout Chronic, Gout, DDI (Drug-Drug Interaction)
Phase 12026-01-23
RecruitingSafety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Acute Gouty Arthritis, Gout Flare, Gout Flares
Phase 22025-08-26
TerminatedExtension Study of ABP-671 in Participants With Gout
Gout
Phase 2 / Phase 32024-04-22
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy V
Gout, Acute Gout Flare, Gout Flares
Phase 12024-01-23
CompletedPhase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
Gout
Phase 2 / Phase 32023-08-11
CompletedA Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia
Gout, Hyperuricemia
Phase 22020-11-27
CompletedStudy to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects
Gout, Food-drug Interaction
Phase 12020-05-22
CompletedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
Hyperuricemia, Gout
Phase 12019-09-05
CompletedA Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjec
Gout, Hyperuricemia
Phase 12018-10-17